Luckwel Pharmaceuticals Inc. (LWEL) financial statements (2021 and earlier)

Company profile

Business Address 303 WYMAN STREET
WALTHAM, MA 02451
State of Incorp. NV
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

3/31/2019
3/31/2018
3/31/2017
2/29/2016
2/28/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments26192911748
Cash and cash equivalents26192911748
Other undisclosed current assets  180 
Total current assets:26194711748
Noncurrent Assets
Intangible assets, net (including goodwill)   (55)(37)
Intangible assets, net (excluding goodwill)   (55)(37)
Other noncurrent assets  5  
Other undisclosed noncurrent assets   55 
Total noncurrent assets:  5 (37)
Other undisclosed assets2   46
TOTAL ASSETS:27195211757
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:68666812
Employee-related liabilities  32732390
Other undisclosed accounts payable and accrued liabilities6866(260)(31)(388)
Due to related parties75182327  
Other undisclosed current liabilities   32 
Total current liabilities:819148395332
Noncurrent Liabilities
Other undisclosed liabilities    390
Total liabilities:81914839533393
Stockholders' equity
Stockholders' equity attributable to parent, including:(792)(129)(342)84(526)
Common stock1,434184176175105
Additional paid in capital4661,71697385686
Accumulated other comprehensive income00000
Accumulated deficit(2,691)(2,029)(1,492)(947)(526)
Other undisclosed stockholders' equity attributable to parent    (191)
Other undisclosed stockholders' equity    191
Total stockholders' equity:(792)(129)(342)84(335)
TOTAL LIABILITIES AND EQUITY:27195211757

Income statement (P&L) ($ in thousands)

3/31/2019
3/31/2018
3/31/2017
2/29/2016
2/28/2015
Other income0 (60)0
Gross profit:0  0 
Operating expenses(623)(533)(451)(421)(265)
Operating loss:(623)(533)(511)(421)(265)
Nonoperating expense (4)   
Investment income, nonoperating (4)   
Net loss:(623)(537)(511)(421)(265)
Other undisclosed net income attributable to parent    1
Net loss available to common stockholders, diluted:(623)(537)(511)(421)(264)

Comprehensive Income ($ in thousands)

3/31/2019
3/31/2018
3/31/2017
2/29/2016
2/28/2015
Net loss:(623)(537)(511)(421)(265)
Comprehensive loss, net of tax, attributable to parent:(623)(537)(511)(421)(265)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: